Skye Bioscience, Inc. (SKYE)
0.93
-0.07
(-6.99%)
USD |
NASDAQ |
Dec 19, 16:00
0.931
0.00 (0.00%)
After-Hours: 20:00
Skye Bioscience Shareholders Equity (Annual): 68.15M for Dec. 31, 2024
Shareholders Equity (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Annual) Benchmarks
| Perspective Therapeutics, Inc. | 290.67M |
| Theravance Biopharma, Inc. | 175.54M |
| Viking Therapeutics, Inc. | 880.28M |
| FibroGen, Inc. | -225.60M |
| Myomo, Inc. | 24.71M |